VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $964,801 | +4.1% | 95,242 | +3.4% | 0.01% | 0.0% |
Q4 2023 | $926,707 | -0.2% | 92,118 | -7.1% | 0.01% | -12.5% |
Q3 2023 | $928,745 | -61.6% | 99,119 | +0.7% | 0.01% | -61.9% |
Q2 2023 | $2,415,665 | +18.0% | 98,478 | +11.9% | 0.02% | +16.7% |
Q1 2023 | $2,047,132 | -10.3% | 87,973 | -2.5% | 0.02% | -10.0% |
Q4 2022 | $2,283,266 | +63.6% | 90,212 | +24.6% | 0.02% | +53.8% |
Q3 2022 | $1,396,000 | -41.4% | 72,418 | -22.6% | 0.01% | -43.5% |
Q2 2022 | $2,383,000 | +511.0% | 93,544 | +516.6% | 0.02% | +475.0% |
Q1 2022 | $390,000 | -94.4% | 15,170 | -90.5% | 0.00% | -94.0% |
Q3 2021 | $6,967,000 | -13.7% | 160,089 | -6.3% | 0.07% | -5.6% |
Q2 2021 | $8,074,000 | -23.7% | 170,779 | -17.3% | 0.07% | -31.1% |
Q1 2021 | $10,583,000 | +72.1% | 206,416 | -10.1% | 0.10% | +49.3% |
Q4 2020 | $6,150,000 | +10.6% | 229,652 | +41.7% | 0.07% | -15.9% |
Q3 2020 | $5,562,000 | -15.6% | 162,029 | +0.7% | 0.08% | -6.8% |
Q2 2020 | $6,589,000 | – | 160,827 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |